InMode Ltd. Ordinary Shares
INMD Real Time Price USDRecent trades of INMD by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by INMD's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Method for treatment of erectile dysfunction Sep. 03, 2024
-
Patent Title: Methods for treating urinary stress incontinence Aug. 13, 2024
-
Patent Title: Fractional treatment of urinary incontinence Mar. 12, 2024
-
Patent Title: Nasal tissue treatment method and related device Feb. 13, 2024
-
Patent Title: Rf fractional device for treatment at different tissue depths Oct. 10, 2023
-
Patent Title: Rf device for tissue treatment May. 23, 2023
-
Patent Title: Reflector for intense pulse light device Apr. 11, 2023
-
Patent Title: Method for enhanced electro-muscle stimulation Oct. 11, 2022
-
Patent Title: Device and method for treatment of sleep disorders Apr. 05, 2022
-
Patent Title: Skin rejuvenation resurfacing device and method of use Oct. 13, 2020
-
Patent Title: Light source and fluid conduit assembly Jun. 16, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of INMD in WallStreetBets Daily Discussion
Recent insights relating to INMD
Recent picks made for INMD stock on CNBC
ETFs with the largest estimated holdings in INMD
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view INMD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.